MedTrace Logo

Assessment of the Impact of Real-Time Continuous Glucose Monitoring on People Presenting With Severe Hypoglycaemia

NCT03748433 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2024-03-22

Study results available
· View outcomes & findings →

Summary

This study aims to assess the impact of real-time continuous glucose monitoring on the frequency, duration, awareness and severity of hypoglycaemia in people with type 1 diabetes and a recent history of severe hypoglycaemia, compared to usual care.

Conditions

  • Diabetes Mellitus, Type 1
  • Hypoglycemia Unawareness
  • Hypoglycemia

Interventions

DEVICE

Dexcom G6 CGM

Commercially available Dexcom G6 Continuous Glucose Monitoring

DEVICE

Tandem t:slim X2 Insulin Pump

sensor augmented insulin pump with predictive low glucose suspend

Sponsors & Collaborators

  • London Ambulance Service

    collaborator OTHER

  • Imperial College London

    lead OTHER

Principal Investigators

  • Nick Oliver · Imperial College London

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-03
Primary Completion
2021-09-09
Completion
2021-09-09

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03748433 on ClinicalTrials.gov